Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
109
92
71
62
61
43
Crecimiento de los Ingresos (YoY)
24%
30%
15%
2%
42%
79%
Costo de los ingresos
37
32
28
23
25
19
Utilidad bruta
71
59
42
38
35
24
Venta, General y Administración
60
61
58
49
33
23
Investigación y Desarrollo
--
--
--
--
--
1
Gastos de Operación
65
65
60
51
35
26
Otras Ingresos (Gastos) No Operativos
0
0
0
--
0
0
Ingreso antes de impuestos
1
-19
-25
-11
0
-2
Gasto por Impuesto a la Renta
1
0
-7
0
0
0
Ingreso Neto
0
-20
-17
-11
0
-2
Crecimiento de la Utilidad Neta
-100%
18%
55%
--
-100%
-33%
Acciones en Circulación (Diluidas)
19.45
18.29
17.12
17.78
17.69
14.83
Cambio de Acciones (YoY)
8%
7%
-4%
1%
19%
11%
EPS (Diluido)
0
-1.09
-1.02
-0.64
0.02
-0.15
Crecimiento de EPS
-100%
7%
60%
-3,300%
-112.99%
-35%
Flujo de efectivo libre
11
4
-8
10
0
-6
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
65.13%
64.13%
59.15%
61.29%
57.37%
55.81%
Margen de operación
5.5%
-6.52%
-23.94%
-19.35%
0%
-4.65%
Margen de beneficio
0%
-21.73%
-23.94%
-17.74%
0%
-4.65%
Margen de flujo de caja libre
10.09%
4.34%
-11.26%
16.12%
0%
-13.95%
EBITDA
10
-2
-15
-10
2
0
Margen de EBITDA
9.17%
-2.17%
-21.12%
-16.12%
3.27%
0%
D&A para EBITDA
4
4
2
2
2
2
EBIT
6
-6
-17
-12
0
-2
Margen de EBIT
5.5%
-6.52%
-23.94%
-19.35%
0%
-4.65%
Tasa de Impuesto Efectiva
100%
0%
28%
0%
0%
0%
Estadísticas clave
Cierre Anterior
$8.21
Precio de apertura
$8.22
Rango del día
$8.09 - $9.05
Rango de 52 semanas
$3.99 - $22.25
Volumen
438.1K
Volumen promedio
288.3K
EPS (TTM)
-0.00
Rendimiento de dividendos
--
Cap. de mercado
$163.1M
¿Qué es OPRX?
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.